Ocugen (OCGN) Non-Current Deffered Revenue (2014 - 2019)
Ocugen (OCGN) posted Non-Current Deffered Revenue of $10.0 million for Q2 2019, little changed on a QoQ basis from $10.0 million in Q1 2019, and up 3054.57% year-over-year from $317000.0 in Q2 2018.
Ocugen (OCGN) Non-Current Deffered Revenue (2014 - 2019) Analysis & Trends
Ocugen's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $10.0 million for Q2 2019.
- Quarterly Non-Current Deffered Revenue rose 3054.57% year-over-year to $10.0 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $10.0 million (up 3054.57% YoY) and the FY2018 annual result came in at $3739.0, down 98.66% from the prior year.
- Non-Current Deffered Revenue was $10.0 million for Q2 2019 at Ocugen, roughly flat from $10.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $10.0 million in Q1 2019 and bottomed at $3739.0 in Q4 2018.
- A 5-year average of $1.9 million and a median of $382500.0 in 2015 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2018 — Non-Current Deffered Revenue sank 98.66% — and 2019, when it soared 3054.57%.
- Ocugen's Non-Current Deffered Revenue stood at $451000.0 in 2015, then slumped by 30.16% to $315000.0 in 2016, then slipped by 11.11% to $280000.0 in 2017, then sank by 98.66% to $3739.0 in 2018, then jumped by 267351.19% to $10.0 million in 2019.
- Business Quant data shows OCGN's Non-Current Deffered Revenue at $10.0 million in Q2 2019, $10.0 million in Q1 2019, and $3739.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 10.00 Mn |
| Mar 31, 2019 | 10.00 Mn |
| Dec 31, 2018 | 3,739.00 |
| Sep 30, 2018 | 5.00 Mn |
| Jun 30, 2018 | 317,000.00 |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | 280,000.00 |
| Sep 30, 2017 | 289,000.00 |
| Jun 30, 2017 | 298,000.00 |
| Mar 31, 2017 | 308,000.00 |
| Dec 31, 2016 | 315,000.00 |
| Sep 30, 2016 | 349,000.00 |
| Jun 30, 2016 | 384,000.00 |
| Mar 31, 2016 | 418,000.00 |
| Dec 31, 2015 | 451,000.00 |
| Sep 30, 2015 | 381,000.00 |
| Jun 30, 2015 | 413,000.00 |
| Mar 31, 2015 | 445,000.00 |
| Dec 31, 2014 | 379,000.00 |